MLTX

Healthcare

MoonLake Immunotherapeutics

$17.15+0.12 (+0.70%)

Prev Close

$17.03

Open

$17.14

High

$17.79

Low

$17.06

Volume

535.8K

Market Cap

$1.30B

P/E

—

Div Yield

—

Over the past 12 months, insider activity at MoonLake Immunotherapeutics (MLTX) has been dominated by selling, with 1 insider purchase totaling $98.8K and 4 insider sales totaling $54.00M. The most recent insider transaction was by Reich Kristian (Chief Scientific Officer), who sold $3.01M worth of shares on Dec 8, 2025. MoonLake Immunotherapeutics operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.30B.

Buys (12M)

$98.8K

Sells (12M)

$54.00M

Net Activity

Net Seller

$53.90M

Active Insiders

last 12 mo

MLTX Price Chart

MLTX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value
Dec 8, 2025↗	Reich Kristian	Chief Scientific Officer	Sell	202,908	$14.85	$3.01M
Dec 8, 2025↗	Santos da Silva Jorge	Chief Executive Officer	Sell	200,000	$14.87	$2.97M
Oct 8, 2025↗	Bodenstedt Matthias	Chief Financial Officer	Buy	10,870	$9.09	$98.8K
Sep 29, 2025↗	Chen Bihua	Insider	Sell	6,499,978	$7.21	$46.87M
Jul 3, 2025↗	Moukheibir Catherine	Director	Sell	23,500	$48.79	$1.15M

MLTX Insider Buying Activity

The following table shows recent insider purchases of MoonLake Immunotherapeutics (MLTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 8, 2025↗	Bodenstedt Matthias	Chief Financial Officer	Buy	10,870	$9.09	$98.8K	0

MLTX Insider Selling Activity

The following table shows recent insider sales of MoonLake Immunotherapeutics (MLTX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Dec 8, 2025↗	Reich Kristian	Chief Scientific Officer	Sell	202,908	$14.85	$3.01M
Dec 8, 2025↗	Santos da Silva Jorge	Chief Executive Officer	Sell	200,000	$14.87	$2.97M
Sep 29, 2025↗	Chen Bihua	Insider	Sell	6,499,978	$7.21	$46.87M
Jul 3, 2025↗	Moukheibir Catherine	Director	Sell	23,500	$48.79	$1.15M